Potentially Infected Articles & Analysis
20 news found
Overall, patients need to know that the lower their Ct is the more indicative the result is of heavy infection and potentially, the more infectious they are for those around them. ...
The concept is analogous to breakaway devices that help prevent hazardous fuel spills when a customer at a gas station mistakenly drives away with the gas nozzle still in the fuel tank. Potential advantages of the valve include: For nurses: Greater efficiency through avoiding dislodgements and unscheduled IV restarts Less exposure to sharps injuries and ...
“Our evaluation confirmed the great potential for the Orchid SRV and Linear’s platform technology, which is designed to meet a critically important unmet clinical need. ...
The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in vascular see all too often,” said focus group participant Kevin Botelho, RN, BSN, VA-BC, a vascular access specialist at Concord Hospital, in ...
“These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” said Matthew Henn, Ph.D., Chief Scientific Officer at Seres. ...
Lost in the surgical backlog, already delayed diagnoses may be further delayed, potentially lowering patient outcomes. That’s why early detection is crucial; for patients with local to regional prostate cancer (PCa), the 5 year survival rate is nearly 100%, but drops to 30% once the cancer begins to spread to other organs.1 The current standard diagnostic pathway is a PSA ...
The patented RPIDD method is going to revolutionize the traditional first line clinical diagnostics for infectious diseases such as blood culture, PCR (etc), and we are convinced that a rapid molecular liquid biopsy based diagnostics approach for infectious diseases will disrupt the current approaches and hence in due course potentially reduce infected ...
In this trial, we expect to generate data that will highlight the broad therapeutic potential of our lead compound zapnometinib, a dual-effect MEK-inhibitor that is expected to work against all existing variants of SARS-CoV-2. ...
For patients undergoing peritoneal dialysis (PD), rates of infection-driven hospitalization are as high as 0.5 hospitalizations per patient year, according to the U.S. ...
The application is specified for the indication osteomyelitis (bone infection) and can potentially result in an approval in Q1 of 2022. In February of this year, the FDA requested further data and clarifications on BONESUPPORT’s DeNovo application. ...
According to the World Health Organization, “People in close contact with someone who is infected with a virus, such as the Ebola or COVID virus, are at higher risk of becoming infected themselves, and of potentially further infecting others. ...
ByBioVigil
There is now a greater awareness of the benefits of non-contact in regard to infection control, as a result of the Covid-19 pandemic. The company now distributes TRITEMP in over 21 countries across the globe, listed on major procurement frameworks including NHS Supply Chain. ...
According to Alexander Kretschmer, M.D., Assistant Professor of Urology at Ludwig-Maximilians-University Munich, "From a clinical perspective, deferring biopsy can help a patient avoid the undesirable complications from a biopsy, such as pain, hematuria, infection and potentially hospitalization. Many patients are frightened to undergo the biopsy procedure; ...
As a manufacturer MWS took the decision to remain open during the last lockdown to support our Pharmaceutical, Food and Chemical clients plus many other businesses involved in the supply chain of these industries. After considering the potential risks and discussing with MWS managers the Directors have decided that MWS will remain open to provide continued support to our valued ...
Nanovis is an award-winning bio-device technology company committed to helping surgeons, hospitals, and patients achieve excellent fixation and infection outcomes using advanced tech platforms. Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. Nanovis’ developmental infection ...
ByNanovis
The prolonged use of ETTs in the ICU is often life-saving, but life-threatening infections and complications occur in a significant portion of patients. C. auris and other Candida fungal infections in ETTs are of high clinical concern and can lead to patient morbidity and mortality. ...
TOPS technology allows the development of devices that are designed to be more cost-effective, smaller, and longer lasting, requiring fewer lifetime replacements and reducing the potential for infection and other complications. DBI was formed in 2012 as a portfolio company of NDI Medical, LLC. About NDI Founded in 2002, NDI is a hybrid venture capital and ...
Traditionally, MRSA infections were associated with healthcare acquired infections (HAIs). In recent years there has been a growing trend of these potentially deadly infections coming from the community. According to the Delaware Health Statistics Center (DHSC), “The number of MRSA discharges in Delaware hospitals more ...
The article discusses a new study conducted by The Barts and The London NHS Trust that found 30 different types of possible infections in pillows taken from hospital wards. Potential exposure to C. diff and MRSA were just a few of the potentially deadly pathogens discussed in the report. Methicillin-resistant Staphylococcus aureus (MRSA) ...
Invasive aspergillosis most commonly affects the lungs, but can also cause infection in many other organs and can spread throughout the body.” Although the study group was small, the findings appear to indicate that there is a growing dissemination of drug-resistant strains of Aspergillus fungi. Azole antifungal agents are a common option for the treatment of systemic ...
